C. Brazell

1.1k total citations
22 papers, 793 citations indexed

About

C. Brazell is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, C. Brazell has authored 22 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in C. Brazell's work include Neuroscience and Neuropharmacology Research (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). C. Brazell is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). C. Brazell collaborates with scholars based in United Kingdom, United States and Canada. C. Brazell's co-authors include R. Gill, Stephen M. Stahl, Mark D. Tricklebank, François Gilbert, G.N. Woodruff, J A Kemp, Richard Hatfield, Colin T. Dourish, Steven J. McClue and Andrew C. Nelsen and has published in prestigious journals such as Biological Psychiatry, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

C. Brazell

21 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Brazell United Kingdom	14	370	219	161	119	95	22	793
S.K. Kulkarni India	20	357 1.0×	237 1.1×	103 0.6×	124 1.0×	136 1.4×	46	1.1k
Mehrak Javadi‐Paydar Iran	19	362 1.0×	259 1.2×	174 1.1×	210 1.8×	53 0.6×	43	924
Michael A. Ackley United States	13	401 1.1×	287 1.3×	97 0.6×	152 1.3×	62 0.7×	22	859
B. Bondy Germany	8	190 0.5×	235 1.1×	166 1.0×	99 0.8×	40 0.4×	13	948
Sami Anttila Finland	18	229 0.6×	214 1.0×	269 1.7×	100 0.8×	26 0.3×	27	1.1k
M. N. Subhash India	18	318 0.9×	250 1.1×	112 0.7×	105 0.9×	38 0.4×	46	870
Cherie E. Bond United States	12	493 1.3×	363 1.7×	216 1.3×	349 2.9×	37 0.4×	15	1.2k
Hiroshi Suwaki Japan	19	400 1.1×	326 1.5×	62 0.4×	94 0.8×	45 0.5×	85	1.1k
Dale L. Birkle United States	19	261 0.7×	433 2.0×	176 1.1×	188 1.6×	236 2.5×	46	1.5k

Countries citing papers authored by C. Brazell

Since Specialization

Citations

This map shows the geographic impact of C. Brazell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Brazell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Brazell more than expected).

Fields of papers citing papers by C. Brazell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Brazell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Brazell. The network helps show where C. Brazell may publish in the future.

Co-authorship network of co-authors of C. Brazell

This figure shows the co-authorship network connecting the top 25 collaborators of C. Brazell. A scholar is included among the top collaborators of C. Brazell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Brazell. C. Brazell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kazeem, Gbenga, Charles Cox, Jennifer L. Aponte, et al.. (2009). High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients. Pharmacogenetics and Genomics. 19(9). 661–665. 85 indexed citations

Mendrick, Donna L., C. Brazell, Elizabeth Mansfield, et al.. (2006). Pharmacogenomics and regulatory decision making: an international perspective. The Pharmacogenomics Journal. 6(3). 154–157. 4 indexed citations

Webster, Chris, Susan Ide, Nadine Cohen, et al.. (2005). RETURNING GENETIC RESEARCH RESULTS TO INDIVIDUALS: POINTS‐TO‐CONSIDER. Bioethics. 20(1). 24–36. 69 indexed citations

Brazell, C., Andrew Freeman, & Michael Mosteller. (2002). Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillance. British Journal of Clinical Pharmacology. 53(3). 224–231. 21 indexed citations

Anderson, DC, Baltazar Gomez‐Mancilla, B B Spear, et al.. (2002). Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group. The Pharmacogenomics Journal. 2(5). 284–292. 28 indexed citations

Foot, Elizabeth, Pierre‐Philippe Sagnier, Michael Zuehlsdorf, et al.. (2001). . International Journal of Pharmaceutical Medicine. 15(2). 95–100. 2 indexed citations

Foot, Elizabeth, Florian Bieber, Pierre‐Philippe Sagnier, et al.. (2001). Impact of pharmacogenetics on health care and health economics. International Journal of Pharmaceutical Medicine. 15(2). 95–100. 1 indexed citations

O'Hara, C M, et al.. (1994). Administration of aerosol pentamidine: a program design.. PubMed. 5(2). 41–8. 3 indexed citations

Hatfield, Richard, R. Gill, & C. Brazell. (1992). The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischemia model. European Journal of Pharmacology. 216(1). 1–7. 82 indexed citations

10.

Rupniak, N.M.J., et al.. (1992). Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates. Journal of the Neurological Sciences. 107(2). 246–249. 29 indexed citations

11.

Brazell, C., et al.. (1991). 5-Hydroxytryptamine (5-HT)-induced shape change in human platelets determined by computerized data acquisition. Blood Coagulation & Fibrinolysis. 2(1). 17–24. 6 indexed citations

12.

Lines, Christopher R., et al.. (1991). The effects of pre-treatment with enalapril maleate on scopolamine-induced cognitive deficits in healthy volunteers. Journal of Psychopharmacology. 5(3). 228–233. 4 indexed citations

13.

Gill, R., C. Brazell, G.N. Woodruff, & J A Kemp. (1991). The neuroprotective action of dizocilpine (MK‐801) in the rat middle cerebral artery occlusion model of focal ischaemia. British Journal of Pharmacology. 103(4). 2030–2036. 120 indexed citations

14.

Willis, Colin L., et al.. (1991). Plasma and CSF levels of dizocilplne (MK-801) required for neuroprotection in the quinolinate-injected rat striatum. European Journal of Pharmacology. 196(3). 285–290. 18 indexed citations

15.

Mitchell, Stephen N., et al.. (1990). 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration. Biochemical Pharmacology. 39(1). 161–166. 17 indexed citations

16.

Brazell, C., et al.. (1989). MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype. Neuroscience Letters. 105(1-2). 174–176. 40 indexed citations

17.

McClue, Steven J., C. Brazell, & Stephen M. Stahl. (1989). Hallucinogenic drugs are partial agonists of the human platelet shape change response: A physiological model of the 5-HT2 receptor. Biological Psychiatry. 26(3). 297–302. 16 indexed citations

18.

Brazell, C., G. C. Preston, C. Ward, Christopher R. Lines, & Michael Traub. (1989). The scopolamine model of dementia: chronic transdermal administration. Journal of Psychopharmacology. 3(2). 76–82. 7 indexed citations

19.

Gilbert, François, C. Brazell, Mark D. Tricklebank, & Stephen M. Stahl. (1988). Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. European Journal of Pharmacology. 147(3). 431–439. 146 indexed citations

20.

Gilbert, Fiona J., Colin T. Dourish, C. Brazell, Steven J. McClue, & Stephen M. Stahl. (1988). Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats. Psychoneuroendocrinology. 13(6). 471–478. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact